Featured Research

from universities, journals, and other organizations

New findings challenge view of key part of immune defense

Date:
March 3, 2011
Source:
Ume University
Summary:
The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass. This is shown in a study regarding vole fever.

The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass. This is shown in a study regarding vole fever that was recently published by researchers at Ume University, Sweden in Journal of Experimental Medicine.

Related Articles


These are findings of a years-long project where patients with vole fever, a northern Swedish hemorrhagic fever that has been studied with regard to natural killer (NK) cells. Vole fever is a common infection in northern Sweden that is caused by a hantavirus, Puumala virus, which is prevalent in bank voles and infects humans primarily via inhalation of virus-contaminated dust.

The symptoms are primarily high fever, head and muscle pain, abdominal pain, and generally impacted condition. Involvement of the kidneys and lungs are common. There is no dedicated and effective treatment today. As vole fever is a hemorrhagic fever, there is often a pronounced reduction in blood platelets, and bleeding complications occur. Some 30 % of the diagnosed cases are hospitalized. Mortality is 0.5 % owing to bleeding, shock, and multiple organ failure.

The Ume researchers, led by assistant professor Clas Ahlm, have used a unique patient cohort to study the expansion of NK cells and their activity in the course of the infection in collaboration with scientists at the Karolinska institute. The material was gathered during and following the major outbreak of vole fever in 2007. There have been few previous studies of NK cells in acute viral infections in humans, even though they are regarded as part of our so-called innate immunity. The Puumala virus itself is not cytopatogenic, i.e. doesn't kill the infected cells. The Ume scientists' hypothesis is therefore that part of the pathological mechanism in vole fever involves the immune defense against the virus infection, which is further supported by these findings.

The study revealed an expansion of NK cells. This expansion persisted for an extended period after the acute infection, which surprised the researchers. This finding challenges to some extent the previous view that the elevation and activation of NK cells quickly subsides in acute viral infections. The results of the study indicate that some NK cells may have memory-like functions.


Story Source:

The above story is based on materials provided by Ume University. Note: Materials may be edited for content and length.


Journal Reference:

  1. N. K. Bjorkstrom, T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaelsson, K.-J. Malmberg, J. Klingstrom, C. Ahlm, H.-G. Ljunggren. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. Journal of Experimental Medicine, 2010; 208 (1): 13 DOI: 10.1084/jem.20100762

Cite This Page:

Ume University. "New findings challenge view of key part of immune defense." ScienceDaily. ScienceDaily, 3 March 2011. <www.sciencedaily.com/releases/2011/03/110302121936.htm>.
Ume University. (2011, March 3). New findings challenge view of key part of immune defense. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2011/03/110302121936.htm
Ume University. "New findings challenge view of key part of immune defense." ScienceDaily. www.sciencedaily.com/releases/2011/03/110302121936.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins